VAM
KZR

Vazirani Asset Management’s Kezar Life Sciences KZR Stock Holding History

Vazirani Asset Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$163K Sell
22,000
-26,428
-55% -$172K 0.38% 19
2025
Q4 		$305K Buy
+48,428
New +$282K 1.85% 10

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Vazirani Asset Management's KZR Position: Q1 2026 in Review

Vazirani Asset Management reduced its Kezar Life Sciences (KZR) stake by 55% in Q1 2026, selling an estimated $172K and leaving 22,000 shares worth $163K. The position accounts for 0.38% of the portfolio, ranked #19.

Vazirani Asset Management first reported a position in KZR in Q4 2025 and has held it in 2 quarters since. The position peaked at $305K in Q4 2025. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

  • Vazirani Asset Management held 22,000 shares of Kezar Life Sciences worth $163K as of Q1 2026.
  • Vazirani Asset Management sold 26,428 Kezar Life Sciences shares in Q1 2026, an estimated $172K.
  • Kezar Life Sciences made up 0.38% of Vazirani Asset Management's portfolio in Q1 2026, its #19 holding.
  • Vazirani Asset Management first reported a position in Kezar Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • Vazirani Asset Management's Kezar Life Sciences position peaked at $305K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Vazirani Asset Management's 13F filing for Q1 2026, filed 15 May 2026.